While effective, both GLP-1 agonists and SGLT2 inhibitors should complement lifestyle interventions, including diet, exercise, and weight management
Understanding Your Mounjaro Dosing Schedule and How Mounjaro Works How Mounjaro works What to Do After Missing a Mounjaro Dose The Impact of a Missed Mounjaro Dose on Your Treatment Journey Restarting Mounjaro After a Significant Break How to Prevent Missing Future Mounjaro Doses When to Contact Your Healthcare Provider References We all know the importance of taking regular medications on time, but sometimes life gets in the way
Common Injection Site Reactions With GLP-1 Therapy The most frequent complaint is acute pain during or immediately after injection, which usually subsides within minutes but can persist as a dull ache for hours
Medications highlighted in the graphic include: Oral Wegovy - GLP-1 receptor agonist - ~13 to 17% estimated weight loss Wegovy 7.2 mg - Higher-dose injectable GLP-1 - ~20 to 21% estimated weight loss Orforglipron - Oral non-peptide GLP-1 agonist - ~11 to 15% estimated weight loss CagriSema - Amylin analog + GLP-1 agonist - ~20 to 23% estimated weight loss Retatrutide - Triple agonist (GIP, GLP-1, glucagon) - up to ~28 to 29% estimated weight loss Survodutide - Dual agonist (GLP-1, glucagon) - ~15 to 19% estimated weight loss MariTide - GIP antagonist + GLP-1 antibody-drug conjugate - ~18 to 20% estimated weight loss A few important notes for context: The percentages shown are trial-based estimates and vary by dose, duration, and analysis method Timelines reflect best estimates, not guarantees Real-world outcomes will depend on access, tolerability, and individualized care That said, the direction is clear
Over time, this leads to weight gain
